Overview

Abdominal migraine is a childhood disorder of gut-brain interaction (DGBI) characterized by paroxysmal episodes of intense, acute, midline abdominal pain accompanied by vasomotor and gastrointestinal symptoms. It is classified under the Rome IV framework within the category of Functional Abdominal Pain Disorders in children and adolescents (Category H2). The condition shares pathophysiological mechanisms with cranial migraine and is widely considered part of the migraine spectrum, although the predominant symptom is abdominal pain rather than headache.

The Rome IV criteria (2016) provide a standardized, symptom-based diagnostic framework that allows clinicians to identify abdominal migraine on clinical grounds, reducing unnecessary invasive testing while promoting early, targeted intervention. A key feature of the Rome IV update is the emphasis that abdominal pain must be the most severe and distressing symptom during episodes, distinguishing abdominal migraine from cyclic vomiting syndrome (CVS), where vomiting predominates.

Historical Context and Nosological Evolution

The concept of abdominal migraine has a long clinical history. The term was used informally in pediatric practice for decades before receiving formal diagnostic criteria. The Rome II classification (1999) first codified abdominal migraine as a recognized functional gastrointestinal disorder in children. Rome III (2006) refined the criteria and clarified the distinction between abdominal migraine, cyclic vomiting syndrome, and functional abdominal pain.

With Rome IV (2016), several important revisions were introduced. The term "functional gastrointestinal disorders" was replaced by "disorders of gut-brain interaction" to reduce stigma and better reflect the bidirectional pathophysiology. The criteria for abdominal migraine were tightened to emphasize that pain must be the predominant symptom. The temporal requirement was standardized at 6 months of symptom presence before diagnosis, aligning with other pediatric DGBIs. The International Headache Society (IHS) also recognizes abdominal migraine in its International Classification of Headache Disorders (ICHD-3), and the Rome IV and ICHD-3 criteria are largely harmonized, though minor differences in associated symptom requirements exist.

Epidemiology

Abdominal migraine affects an estimated 1% to 4% of children in population-based studies, making it one of the more common causes of recurrent abdominal pain in school-age children. Prevalence varies by geography and methodology, with some studies reporting rates as high as 9% when broader definitions are applied. The condition is most frequently diagnosed between the ages of 3 and 10 years, with a peak incidence around 7 years of age. Girls are affected slightly more often than boys, though the sex ratio is less pronounced than that observed in adult migraine.

A strong family history of migraine is present in the majority of cases. Studies consistently show that 50% to 90% of children with abdominal migraine have a first-degree relative with cranial migraine. This familial clustering supports the genetic basis of the disorder and is an important clinical clue when the diagnosis is under consideration.

The natural history of abdominal migraine is generally favorable in terms of the abdominal symptom itself. Most children outgrow their episodes by adolescence. However, longitudinal follow-up studies demonstrate that a substantial proportion (up to 70% in some cohorts) go on to develop cranial migraine headaches in adolescence or adulthood, reinforcing the concept that abdominal migraine is a pediatric expression of the broader migraine phenotype.

Pathophysiology

The Gut-Brain Axis and the Migraine Spectrum

Abdominal migraine is understood as a manifestation of the migraine diathesis, with the gut-brain axis serving as the primary conduit. The enteric nervous system (ENS), sometimes called the "second brain," shares embryological origin, neurotransmitter systems, and receptor expression with the central nervous system (CNS). In genetically susceptible individuals, triggers that would provoke cranial migraine in adults instead produce visceral pain and autonomic symptoms through activation of the trigeminovascular-enteric axis.

Cortical Spreading Depression and Visceral Afferents

Cortical spreading depression (CSD), the electrophysiological phenomenon believed to underlie migraine aura, may also activate brainstem nuclei (particularly the nucleus tractus solitarius and dorsal motor nucleus of the vagus) that project to the gastrointestinal tract via vagal efferents. This central-to-peripheral signaling can produce nausea, vomiting, gastroparesis, altered intestinal motility, and visceral pain. Conversely, visceral afferent signaling from the gut to the brainstem and thalamus may trigger or perpetuate migraine-like central sensitization.

Serotonin (5-HT) Dysregulation

Serotonin plays a pivotal role in both migraine and gastrointestinal physiology. Approximately 95% of the body's serotonin is synthesized and stored in the enterochromaffin cells of the gut. During migraine episodes, platelet serotonin levels decline while urinary 5-hydroxyindoleacetic acid (5-HIAA) excretion rises, indicating serotonin release and metabolism. Serotonin modulates visceral nociception, gastrointestinal motility, and vascular tone. Dysregulation of 5-HT signaling in the gut-brain axis is hypothesized to underlie both the pain and the autonomic/GI symptoms of abdominal migraine.

Calcitonin Gene-Related Peptide (CGRP)

CGRP is a neuropeptide intimately involved in migraine pathogenesis. It is released from trigeminal sensory neurons during migraine attacks and promotes vasodilation, neurogenic inflammation, and central sensitization. CGRP is also expressed in enteric neurons and sensory afferents innervating the gastrointestinal tract. While CGRP-targeted therapies (monoclonal antibodies, gepants) have transformed adult migraine management, their role in abdominal migraine is an active area of investigation.

Autonomic Nervous System Dysfunction

The vasomotor symptoms that accompany abdominal migraine episodes, particularly pallor, suggest autonomic nervous system involvement. Children with abdominal migraine may exhibit baseline autonomic dysfunction, including altered heart rate variability, orthostatic intolerance, and exaggerated sympathetic responses. These autonomic features further link abdominal migraine to the broader migraine phenotype, where autonomic disturbance is a recognized component.

Genetic Susceptibility

The strong familial aggregation of abdominal migraine with cranial migraine points to shared genetic susceptibility. Candidate genes include those involved in ion channel function (CACNA1A, ATP1A2, SCN1A), serotonin metabolism, dopamine receptor expression, and mitochondrial function. Genome-wide association studies in migraine populations have identified multiple risk loci that likely contribute to the pediatric abdominal phenotype, though specific genetic studies focused exclusively on abdominal migraine remain limited.

Rome IV Diagnostic Criteria

The diagnosis of child abdominal migraine requires that all of the following criteria are met. The criteria must have been fulfilled for at least 6 months before diagnosis.

Criterion 1: Paroxysmal Episodes of Intense, Acute Periumbilical, Midline, or Diffuse Abdominal Pain Lasting 1 Hour or More

The pain presents in discrete, clearly delineated episodes rather than as a continuous or daily complaint. Each episode features acute, intense abdominal pain that is typically periumbilical or midline in location, though it may be diffuse. Episodes must last at least 1 hour, and pain must be the most severe and distressing symptom experienced by the child during the attack. This stipulation is critical: if vomiting is more prominent than pain, the clinician should consider cyclic vomiting syndrome instead. The paroxysmal nature of the episodes, with a clear onset and offset, is a hallmark that distinguishes abdominal migraine from functional abdominal pain-not otherwise specified (FAP-NOS), in which pain is more continuous or daily.

Criterion 2: Episodes Are Separated by Weeks to Months

Between attacks, the child returns to baseline health and functions normally. The inter-episode interval is characteristically measured in weeks to months, not days. Daily or near-daily abdominal pain argues against abdominal migraine and should prompt consideration of functional abdominal pain-NOS, irritable bowel syndrome, or other diagnoses. The episodic pattern with complete inter-episode wellness is one of the strongest clinical clues to the diagnosis.

Criterion 3: The Pain Is Incapacitating and Interferes with Normal Activities

During an episode, the pain is severe enough to disrupt the child's normal activities. The child typically cannot attend school, participate in play, or carry out daily routines. Parents often describe the child as immobilized, pale, and withdrawn during attacks. This severity criterion establishes a threshold that separates abdominal migraine from milder, less disruptive forms of recurrent abdominal pain.

Criterion 4: Stereotypical Pattern and Symptoms in the Individual Patient

Each episode follows a recognizable, consistent pattern for that particular child. The onset characteristics, pain location, duration, intensity, and associated symptoms are similar from one episode to the next. Parents can often describe the "typical attack" in considerable detail. This stereotypy reflects the reproducible activation of the same neurobiological cascade during each episode and is a distinguishing feature of the migraine spectrum. Atypical or highly variable presentations should prompt reconsideration of alternative diagnoses.

Criterion 5: The Pain Is Associated with 2 or More of the Following

During episodes, the abdominal pain must be accompanied by at least 2 of the following 6 associated features:

• Anorexia: Loss of appetite during or in the prodromal phase of the episode. The child may refuse food entirely for the duration of the attack.
• Nausea: A sensation of impending emesis that may or may not be followed by vomiting. Nausea is one of the most commonly reported associated symptoms.
• Vomiting: Emesis during the episode. When present, it accompanies but does not overshadow the abdominal pain. If vomiting is the dominant symptom, cyclic vomiting syndrome should be considered.
• Headache: A concurrent headache during the episode reinforces the migraine connection. The headache may precede, coincide with, or follow the abdominal pain. Some children report headache only occasionally, while others experience it with every episode.
• Photophobia: Sensitivity to light during the episode. The child may seek a dark or dimly lit room. Photophobia is a classic migraine feature and, when present, strongly supports the migraine diagnosis.
• Pallor: Visible facial pallor or a "washed-out" appearance is a hallmark vasomotor feature of abdominal migraine. Parents frequently describe the child as looking "ghostly white" or "grey" at the onset of an episode. Pallor reflects the autonomic disturbance that accompanies the migraine cascade.

Criterion 6: Symptoms Cannot Be Fully Explained by Another Medical Condition

After an appropriate clinical evaluation, other organic and structural causes of recurrent abdominal pain must be excluded. The extent of the workup should be guided by the clinical presentation, age of the child, and presence or absence of alarm features (e.g., weight loss, gastrointestinal bleeding, persistent vomiting, fever, localized tenderness, family history of inflammatory bowel disease). The diagnosis of abdominal migraine should be made positively on the basis of its characteristic clinical pattern, not merely by exclusion. However, reasonable exclusion of alternative diagnoses is required.

Temporal Requirement

The Rome IV criteria require that the described symptom pattern has been present for at least 6 months before the diagnosis is established. This temporal filter ensures that the episodic pattern is well established and reproducible, and it guards against premature labeling of an acute or subacute illness as abdominal migraine. In practice, because episodes are separated by weeks to months, 6 months of symptoms typically corresponds to a minimum of 2 to 4 well-characterized episodes, though there is no specified minimum number of episodes.

Clinical Features and Presentation

Typical Episode

A typical abdominal migraine episode begins abruptly with midline or periumbilical pain that escalates to severe intensity within minutes to an hour. The child becomes pale, withdrawn, and inactive. Nausea is almost universally present; vomiting occurs in a subset of episodes. The child may complain of headache and want to lie down in a dark, quiet room (mirroring photophobia and phonophobia seen in cranial migraine). The episode lasts from 1 hour to several days, with most episodes resolving within 4 to 72 hours. Recovery is typically abrupt, and the child returns rapidly to normal function between attacks.

Prodromal and Postdromal Phases

Some children experience a recognizable prodrome in the hours or even 1-2 days before an episode. Prodromal features may include mood changes (irritability, withdrawal, or euphoria), fatigue, food cravings, pallor, or periorbital darkening. A postdromal phase with fatigue, mild residual abdominal discomfort, or altered appetite may persist for hours to a day after the acute pain resolves. These phases further parallel the migraine temporal structure.

Trigger Factors

As with cranial migraine, identifiable triggers are reported by many families. Common triggers include:

• Psychological stress (e.g., school examinations, social conflicts, family disruption)
• Physical exhaustion or altered sleep patterns
• Prolonged fasting or missed meals
• Travel, particularly long car journeys (motion sickness is highly prevalent in these children)
• Certain foods (chocolate, cheese, processed meats containing nitrates, caffeine, and foods with monosodium glutamate have been implicated, though evidence is primarily anecdotal)
• Bright or flickering lights
• Hormonal changes in peri-pubertal girls

Comorbidities

Children with abdominal migraine have elevated rates of several comorbid conditions. Motion sickness is reported in up to 50% to 70% of cases and is one of the most consistent clinical associations. Anxiety and mood disturbance are common, though whether they represent true comorbidity or shared neurobiological susceptibility is debated. Functional GI overlap syndromes, particularly irritable bowel syndrome (IBS), may co-exist. Children with abdominal migraine also appear to have higher rates of other somatic complaints, including limb pain, dizziness, and sleep disturbance.

Differential Diagnosis

The differential diagnosis of episodic, severe abdominal pain in children is broad. Key conditions to consider include:

• Cyclic Vomiting Syndrome (CVS): Also part of the migraine spectrum. The distinguishing feature is that vomiting, not pain, is the predominant symptom. Significant overlap exists, and some children transition between the two diagnoses over time.
• Functional Abdominal Pain - Not Otherwise Specified (FAP-NOS): Chronic or frequently recurring abdominal pain that does not meet criteria for a more specific DGBI. Pain is typically more continuous and does not demonstrate the episodic, stereotypical, paroxysmal pattern of abdominal migraine.
• Irritable Bowel Syndrome (IBS): Pain is related to defecation and associated with changes in stool frequency or form. Overlap with abdominal migraine is possible.
• Inflammatory Bowel Disease (IBD): Crohn disease and ulcerative colitis can present with episodic abdominal pain. Alarm features (bloody stools, weight loss, growth failure, perianal disease, elevated inflammatory markers) should prompt investigation.
• Celiac Disease: Can cause recurrent abdominal pain with variable GI symptoms. Screening with tissue transglutaminase IgA (and total IgA) is straightforward and should be considered in the workup.
• Peptic Ulcer Disease and H. pylori Infection: Epigastric pain related to meals. H. pylori testing should be pursued based on regional prevalence and clinical suspicion.
• Intestinal Obstruction (Including Malrotation with Intermittent Volvulus): Paroxysmal pain with vomiting (especially bilious vomiting) should raise concern for mechanical obstruction. An upper GI series is the diagnostic study of choice for malrotation.
• Ureteropelvic Junction (UPJ) Obstruction: Intermittent hydronephrosis can present with episodic flank or abdominal pain. Renal ultrasound during an episode may be revealing.
• Abdominal Epilepsy: A rare entity in which seizure activity originating from temporal or limbic regions produces paroxysmal abdominal pain. EEG abnormalities and response to antiepileptic medications distinguish this condition.
• Familial Mediterranean Fever (FMF): Periodic episodes of fever and serositis (peritonitis, pleuritis) with abdominal pain. Common in individuals of Mediterranean descent. Genetic testing for MEFV mutations is available.
• Porphyria: Acute intermittent porphyria can cause recurrent abdominal pain with autonomic features. Urine porphobilinogen (PBG) testing during an episode is diagnostic.
• Lead Poisoning: Chronic exposure can produce recurrent colicky abdominal pain. Blood lead levels should be obtained if exposure risk is present.

Diagnostic Approach

History and Physical Examination

The diagnosis of abdominal migraine is primarily clinical. A detailed history should characterize the pain (location, quality, duration, intensity), the episode pattern (frequency, inter-episode wellness, stereotypy), associated symptoms, trigger factors, and functional impact. A thorough family history focusing on migraine, motion sickness, and other periodic syndromes in first-degree relatives is essential. Physical examination between episodes is typically entirely normal. During an episode, the child may appear pale and distressed with mild, diffuse abdominal tenderness but no peritoneal signs, masses, or organomegaly.

Alarm Features Warranting Further Investigation

The following features are not expected in abdominal migraine and should prompt additional evaluation:

• Persistent vomiting, especially if bilious
• Gastrointestinal bleeding (hematemesis, melena, hematochezia)
• Involuntary weight loss or growth failure
• Fever during episodes
• Right upper quadrant or right lower quadrant pain localization
• Dysuria, hematuria, or urinary symptoms
• Nocturnal awakening due to pain
• Family history of inflammatory bowel disease, celiac disease, or peptic ulcer disease
• Onset before age 2 years

Laboratory and Imaging

There is no specific biomarker for abdominal migraine. A reasonable baseline evaluation may include complete blood count (CBC), erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP), comprehensive metabolic panel (CMP), celiac serologies (tissue transglutaminase IgA with total IgA), urinalysis, and stool studies (fecal calprotectin if IBD is a concern). Abdominal ultrasound may be obtained to exclude structural abnormalities (e.g., gallstones, hydronephrosis, ovarian pathology). More invasive testing, such as upper GI series, endoscopy, or CT imaging, should be reserved for cases with alarm features or diagnostic uncertainty. Excessive investigation in the absence of clinical indications should be avoided, as it can reinforce illness behavior and heighten parental anxiety.

The Positive Diagnostic Approach

The Rome Foundation strongly advocates making the diagnosis of abdominal migraine positively, based on the characteristic clinical pattern, rather than treating it purely as a diagnosis of exclusion. The combination of paroxysmal, stereotypical, incapacitating midline abdominal pain with associated vasomotor and GI symptoms, inter-episode wellness, and a family history of migraine is highly suggestive. Communicating the diagnosis confidently and educating the family about the condition are themselves therapeutic and help to curtail the cycle of repeated emergency visits and invasive testing.

Management

General Principles

Management of abdominal migraine encompasses three pillars: lifestyle modification and trigger avoidance, acute episode management, and preventive therapy. The approach should be individualized based on episode frequency, severity, impact on school and social function, and family preferences. A collaborative, empathic therapeutic relationship with the child and family is foundational.

Lifestyle Modification and Trigger Avoidance

Identifying and avoiding known triggers can reduce episode frequency in many children. Practical strategies include:

• Maintaining regular sleep schedules (consistent bedtime and wake time)
• Ensuring regular meals with avoidance of prolonged fasting
• Adequate hydration
• Stress management techniques, including relaxation training, guided imagery, and age-appropriate mindfulness exercises
• Regular physical activity
• An elimination trial of suspected dietary triggers (if a consistent pattern is identified), though blanket restrictive diets are not recommended

Acute Episode Management

During an acute episode, supportive care is the mainstay. The child should be allowed to rest in a quiet, dark environment. Oral or intravenous hydration may be needed if nausea and vomiting are prominent. Pharmacologic options for acute episodes include:

• Simple Analgesics: Ibuprofen and acetaminophen may provide partial relief, particularly when administered early in the episode.
• Triptans: Sumatriptan (intranasal formulation) has been used off-label in older children and adolescents, borrowing from the cranial migraine evidence base. Data specific to abdominal migraine are limited, but clinical experience suggests some benefit given the shared pathophysiology. Use should be guided by age-appropriate prescribing considerations.
• Antiemetics: Ondansetron is useful for managing nausea and vomiting during episodes. Promethazine and prochlorperazine are alternatives but carry higher sedation and extrapyramidal risk.

Preventive Therapy

Prophylactic medication should be considered when episodes are frequent (e.g., more than 1 to 2 per month), prolonged, or significantly impact school attendance and quality of life. Options include:

• Pizotifen: A serotonin antagonist with antihistaminic properties that is widely used outside the United States for abdominal migraine prophylaxis in children. It has the most direct evidence for this indication. Typical dosing is 0.25 to 1.5 mg daily, with weight gain and sedation as the primary side effects.
• Cyproheptadine: A serotonin and histamine antagonist commonly used in younger children (typically under 10 years). Dosing ranges from 2 to 8 mg daily in divided doses. Appetite stimulation and weight gain are common. Sedation is usually transient.
• Propranolol: A non-selective beta-blocker with established efficacy in adult migraine prophylaxis. It is used off-label in pediatric abdominal migraine at doses of 0.5 to 2 mg/kg/day divided twice or three times daily. Contraindicated in children with asthma or significant bradycardia.
• Flunarizine: A calcium channel blocker with anti-migraine properties used widely in Europe and Asia. It is effective for migraine prophylaxis in children, with weight gain and sedation as notable adverse effects.
• Amitriptyline: A tricyclic antidepressant with neuromodulatory and analgesic properties. Low doses (0.2 to 1 mg/kg at bedtime) are used for prophylaxis, particularly in older children and adolescents. ECG screening may be considered before initiation.
• Valproic Acid and Topiramate: Antiepileptic drugs with migraine prophylaxis evidence in adults and children. They are generally reserved for refractory cases due to their side effect profiles.

Psychological and Behavioral Therapies

Cognitive behavioral therapy (CBT) adapted for children with recurrent abdominal pain has demonstrated efficacy in reducing pain frequency, pain intensity, and disability. CBT components include pain education, relaxation training (progressive muscle relaxation, diaphragmatic breathing), cognitive restructuring (addressing catastrophizing and fear-avoidance beliefs), and graded exposure to avoided activities. Gut-directed hypnotherapy, delivered by trained therapists, has shown significant benefit in pediatric functional abdominal pain disorders and may be particularly effective in abdominal migraine given the shared central mechanisms. Biofeedback and guided imagery are additional non-pharmacologic modalities with emerging evidence.

Relationship to Cranial Migraine

Abdominal migraine is recognized as one of the childhood periodic syndromes that are commonly precursors of migraine, a category defined by both the Rome Foundation and the International Headache Society. Other entities in this group include cyclic vomiting syndrome (CVS), benign paroxysmal vertigo of childhood, and benign paroxysmal torticollis of infancy. These conditions share a common pathophysiological substrate: episodic, stereotypical symptoms driven by the migraine cascade, manifesting through different organ systems depending on the child's age and neurodevelopmental stage.

The transition from abdominal migraine to cranial migraine often occurs during late childhood or adolescence. Some children experience a period of overlap, with concurrent abdominal pain and headache during episodes, before the headache becomes the dominant symptom. Understanding this trajectory is important for counseling families: while the abdominal episodes are expected to remit, the child may develop cranial migraine and should be monitored accordingly.

Abdominal Migraine vs. Cyclic Vomiting Syndrome

Abdominal migraine and cyclic vomiting syndrome (CVS) are both migraine-spectrum DGBIs in children, and their clinical overlap can create diagnostic confusion. The Rome IV criteria draw the distinction based on the predominant symptom:

• In abdominal migraine, the most severe and distressing symptom is abdominal pain. Nausea and vomiting may accompany but do not overshadow the pain.
• In CVS, the hallmark is stereotypical episodes of intense, relentless nausea and vomiting. Abdominal pain may be present but is secondary to the emetic symptoms.

Some children exhibit features of both conditions, and the predominant symptom may shift over time. When diagnostic uncertainty exists, the clinical response to migraine-directed therapies (both acute and preventive) can support the shared underlying diagnosis.

Prognosis and Long-Term Outcomes

The prognosis of abdominal migraine in childhood is generally favorable for the abdominal symptom itself. The majority of children experience resolution of abdominal episodes by mid-to-late adolescence. Studies with long-term follow-up report complete remission of abdominal migraine in 50% to 70% of children by age 16 to 18 years.

However, as noted above, transition to cranial migraine is common. Up to 70% of children with abdominal migraine will develop typical migraine headaches during adolescence or adulthood. This natural history underscores the importance of long-term follow-up, migraine education for the family, and anticipatory guidance about potential headache development.

Prognostic factors associated with better outcomes include early diagnosis, effective trigger management, prompt initiation of appropriate prophylaxis when indicated, strong family understanding of the condition, and engagement with psychological therapies. Children who experience prolonged diagnostic delays, unnecessary surgical interventions (e.g., appendectomy for recurrent pain), or excessive school absence may have worse functional outcomes.

Special Considerations

Overlap with Other Pediatric DGBIs

A child may simultaneously meet criteria for abdominal migraine and another DGBI, such as IBS or functional dyspepsia. Dual diagnoses are permitted under the Rome IV framework. When overlap exists, treatment should address both conditions, recognizing that the central mechanisms driving abdominal migraine and the peripheral/motility mechanisms contributing to IBS or dyspepsia may require different therapeutic strategies.

Impact on School Attendance and Quality of Life

Abdominal migraine can significantly impair school attendance, academic performance, and social participation. Children may develop anticipatory anxiety about future episodes, leading to school avoidance that persists even during inter-episode intervals. Addressing these functional consequences requires collaboration between the medical team, school personnel, and the family. Accommodations such as a school health plan, permission to rest in a quiet room during episodes, and flexible attendance policies can reduce the psychosocial burden.

Parental Education and Reassurance

Parental anxiety is a major contributor to healthcare utilization in recurrent pediatric abdominal pain. Providing a clear diagnostic label, explaining the migraine mechanism in age-appropriate and family-appropriate terms, and offering a structured management plan are essential. Families should understand that the condition is real (not fabricated or "in the child's head"), has a well-understood neurobiological basis, is part of the migraine family, and has a favorable long-term prognosis for abdominal symptoms.

Key Clinical Pearls

• Abdominal migraine is a pediatric migraine-spectrum disorder in which paroxysmal abdominal pain (not headache) is the predominant symptom.
• The Rome IV criteria require all mandatory criteria to be met, with symptoms present for at least 6 months. At least 2 of 6 associated symptoms (anorexia, nausea, vomiting, headache, photophobia, pallor) must be present during episodes.
• The inter-episode wellness and stereotypical episode pattern are the strongest diagnostic clues. Daily pain argues against the diagnosis.
• If vomiting, not pain, is the most severe symptom, consider cyclic vomiting syndrome instead.
• A family history of migraine is present in the majority of cases and is an important supportive feature.
• The diagnosis should be made positively on the basis of the characteristic clinical pattern, not solely by exhaustive exclusion of other conditions.
• Most children outgrow abdominal migraine episodes by adolescence, but up to 70% go on to develop cranial migraine headaches.
• First-line preventive agents include cyproheptadine (younger children), pizotifen (outside the US), and propranolol. CBT and gut-directed hypnotherapy are effective non-pharmacologic interventions.
• Avoid excessive diagnostic testing in the absence of alarm features, as it reinforces illness behavior and delays appropriate management.

Calculator Interpretation Guide

This calculator evaluates whether a pediatric patient meets the Rome IV diagnostic criteria for child abdominal migraine by assessing each of the mandatory criteria and the associated symptom requirement (at least 2 of 6 must be present).

• All criteria met (Positive): The patient's presentation is consistent with the Rome IV diagnosis of child abdominal migraine, provided the symptom pattern has been present for the required duration (at least 6 months). The diagnosis should be integrated with the full clinical context, including family history, physical examination findings, and the results of any investigations performed. Clinical correlation is essential.
• One or more criteria not met (Negative): The patient does not fulfill the Rome IV criteria for child abdominal migraine. The specific unmet criteria should guide further evaluation. Alternative diagnoses to consider include cyclic vomiting syndrome, functional abdominal pain-NOS, irritable bowel syndrome, and organic causes of recurrent pediatric abdominal pain.

This tool is intended for educational and clinical decision-support purposes only. It does not constitute medical advice and should not be used as the sole basis for clinical decisions. Always integrate the calculator result with the complete clinical picture and professional judgment.